Zhihao Zou
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Chemo-photothermal synergy ignites antitumor immunity via ferroptosis.
Journal: Signal transduction and targeted therapy
Published: April 30, 2025
Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation.
Journal: Cancer letters
Published: February 26, 2025
SLC15A2 Serves as a Novel Prognostic Biomarker and Target for Prostate Cancer.
Journal: Anticancer research
Published: October 10, 2024
Single-cell and bulk RNA-sequence identify an immune-derived lncRNA-mRNA signature for predicting clinical outcomes and immunotherapeutic response of prostate cancer.
Journal: International journal of biological macromolecules
Published: August 22, 2024
FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation.
Journal: Cell death & disease
Published: September 29, 2023
Evaluation of glucocorticoid-related genes reveals GPD1 as a therapeutic target and regulator of sphingosine 1-phosphate metabolism in CRPC.
Journal: Cancer letters
Published: September 21, 2023
Ferrocene-Based Polymeric Nanoparticles Carrying Doxorubicin for Oncotherapeutic Combination of Chemotherapy and Ferroptosis.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: August 16, 2022
MYPT1 inhibits the metastasis of renal clear cell carcinoma via the MAPK8/N-cadherin pathway.
Journal: FEBS open bio
Published: February 19, 2022
Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer.
Journal: Frontiers in cell and developmental biology
Published: December 08, 2021
Untargeted metabolomics reveals alterations in the metabolic reprogramming of prostate cancer cells by double-stranded DNA-modified gold nanoparticles.
Journal: Biomaterials advances
Published: September 24, 2021
Corrigendum: TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis.
Journal: Frontiers in oncology
Published: July 30, 2021
The prognostic roles of CYP19A1 expression in bladder cancer patients of different genders.
Journal: Translational andrology and urology
Published: May 06, 2021
Last Updated: 09/26/2026